GTAM
AZN icon

Global Trust Asset Management’s AstraZeneca AZN Stock Holding History

Global Trust Asset Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.39K Buy
+39
New +$7.33K ﹤0.01% 355
2026
Q1 		– Sell
-39
Closed -$7.17K – 460
2025
Q4 		$7.17K Buy
+39
New +$6.84K ﹤0.01% 355

Other funds holding AZN

EPGL
Evelyn Partners Group Ltd London $46.9B AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $26.6B AUM
CDDEC
Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $20.1B AUM 16.62% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Global Trust Asset Management's AZN Position: Q2 2026 in Review

Global Trust Asset Management opened a new position in AstraZeneca (AZN) in Q2 2026: 39 shares worth $7.39K. The stake represents ﹤0.01% of the portfolio and ranks #355 among its holdings. This is a return to the name: Global Trust Asset Management previously reported a position in AZN as recently as Q4 2025.

Global Trust Asset Management first reported a position in AZN in Q4 2025 and has held it in 2 quarters since. 906 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Global Trust Asset Management held 39 shares of AstraZeneca worth $7.39K as of Q2 2026.
  • AstraZeneca was a new Global Trust Asset Management position in Q2 2026.
  • AstraZeneca made up ﹤0.01% of Global Trust Asset Management's portfolio in Q2 2026, its #355 holding.
  • Global Trust Asset Management first reported a position in AstraZeneca in Q4 2025 and has held it in 2 quarters since.
  • 906 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Global Trust Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.